Nasus Pharma Ltd.

NSRX | AMEX

Price Alert Chart Builder DCF Calculator

$3.10

+$0.03 (+0.98%)

Nov 2, 2026, 9:30 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022
PE Ratio	-12.71	-48.53	-68.75	-43.42
PEG Ratio	-0.04	-1.16	1.87	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	26.48	n/a	n/a	n/a
P/FCF Ratio	-14.86	-112.39	-72.64	-61.72
P/OCF Ratio	-14.90	-112.39	-72.64	-61.72
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.04	n/a	n/a	n/a
Quick Ratio	2.24	n/a	n/a	n/a
Current Ratio	2.24	n/a	n/a	n/a
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	-37.17	-23.41	-113.44
Return on Equity	-211.56%	n/a	n/a	n/a
Return on Assets	-117.03%	n/a	n/a	n/a
Return on Invested Capital	-169.92%	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a